TY - JOUR
T1 - Aminoglycoside Toxicity
T2 - A Comment-Reply
AU - Campochiaro, Peter A.
AU - Conway, Brian P.
PY - 1992/12
Y1 - 1992/12
N2 - We would like to thank Dr Ben-nun for his interest in our article. He is correct that the vast majority of patients in our survey were treated with other intravitreous drugs in addition to aminoglycosides. However, there are several reasons why we believe that the aminoglycosides were responsible for the macular infarctions. First, while a wide variety of antibiotics were used in the cases reported in our survey, the only medications that they all had in common were aminoglycosides. Second, since we reported the occurrence of macular infarction after intravitreous injection of therapeutic doses of antibiotics,1 we have been made aware of numerous anecdotal cases of macular infarction, and in each case, an aminoglycoside was used. Third, in primates, intravitreous injection of gentamicin can cause macular infarction,2 while intravitreous injection of large doses of other antibiotics, including cefazolin and ceftazidime, does not cause any vascular nonperfusion.
AB - We would like to thank Dr Ben-nun for his interest in our article. He is correct that the vast majority of patients in our survey were treated with other intravitreous drugs in addition to aminoglycosides. However, there are several reasons why we believe that the aminoglycosides were responsible for the macular infarctions. First, while a wide variety of antibiotics were used in the cases reported in our survey, the only medications that they all had in common were aminoglycosides. Second, since we reported the occurrence of macular infarction after intravitreous injection of therapeutic doses of antibiotics,1 we have been made aware of numerous anecdotal cases of macular infarction, and in each case, an aminoglycoside was used. Third, in primates, intravitreous injection of gentamicin can cause macular infarction,2 while intravitreous injection of large doses of other antibiotics, including cefazolin and ceftazidime, does not cause any vascular nonperfusion.
UR - http://www.scopus.com/inward/record.url?scp=84948723704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84948723704&partnerID=8YFLogxK
U2 - 10.1001/archopht.1992.01080240020008
DO - 10.1001/archopht.1992.01080240020008
M3 - Letter
AN - SCOPUS:84948723704
SN - 0003-9950
VL - 110
SP - 1683
JO - Archives of ophthalmology
JF - Archives of ophthalmology
IS - 12
ER -